Wan Y - Search Results

1

Retraction Note: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.

Krzeszinski JY, Wei W, Huynh H, Jin Z, Wang X, Chang TC, Xie XJ, He L, Mangala LS, Lopez-Berestein G, Sood AK, Mendell JT, Wan Y. Krzeszinski JY, et al. Among authors: wan y. Nature. 2020 Jun;582(7810):134. doi: 10.1038/s41586-020-2273-1. Nature. 2020. PMID: 32483375 Free PMC article.

2

miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.

Krzeszinski JY, Wei W, Huynh H, Jin Z, Wang X, Chang TC, Xie XJ, He L, Mangala LS, Lopez-Berestein G, Sood AK, Mendell JT, Wan Y. Krzeszinski JY, et al. Among authors: wan y. Nature. 2014 Aug 28;512(7515):431-5. doi: 10.1038/nature13375. Epub 2014 Jun 25. Nature. 2014. Retraction in: Nature. 2020 Jun;582(7810):134. doi: 10.1038/s41586-020-2273-1 PMID: 25043055 Free PMC article. Retracted.

3

Author Correction: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.

Krzeszinski JY, Wei W, Huynh H, Jin Z, Wang X, Chang TC, Xie XJ, He L, Mangala LS, Lopez-Berestein G, Sood AK, Mendell JT, Wan Y. Krzeszinski JY, et al. Among authors: wan y. Nature. 2019 Jun;570(7761):E51. doi: 10.1038/s41586-019-1266-4. Nature. 2019. PMID: 31127195

4

HDAC9 Inhibits Osteoclastogenesis via Mutual Suppression of PPARγ/RANKL Signaling.

Jin Z, Wei W, Huynh H, Wan Y. Jin Z, et al. Among authors: wan y. Mol Endocrinol. 2015 May;29(5):730-8. doi: 10.1210/me.2014-1365. Epub 2015 Mar 20. Mol Endocrinol. 2015. PMID: 25793404 Free PMC article.

5

New therapeutic targets for cancer bone metastasis.

Krzeszinski JY, Wan Y. Krzeszinski JY, et al. Among authors: wan y. Trends Pharmacol Sci. 2015 Jun;36(6):360-73. doi: 10.1016/j.tips.2015.04.006. Epub 2015 May 9. Trends Pharmacol Sci. 2015. PMID: 25962679 Free PMC article. Review.

6

A Liver-Bone Endocrine Relay by IGFBP1 Promotes Osteoclastogenesis and Mediates FGF21-Induced Bone Resorption.

Wang X, Wei W, Krzeszinski JY, Wang Y, Wan Y. Wang X, et al. Among authors: wan y. Cell Metab. 2015 Nov 3;22(5):811-24. doi: 10.1016/j.cmet.2015.09.010. Epub 2015 Oct 8. Cell Metab. 2015. PMID: 26456333 Free PMC article.

7

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling.

Wei W, Wan Y. Wei W, et al. Among authors: wan y. PPAR Res. 2011;2011:867180. doi: 10.1155/2011/867180. Epub 2011 Oct 29. PPAR Res. 2011. PMID: 22135675 Free PMC article.

8

HDAC7 inhibits osteoclastogenesis by reversing RANKL-triggered β-catenin switch.

Jin Z, Wei W, Dechow PC, Wan Y. Jin Z, et al. Among authors: wan y. Mol Endocrinol. 2013 Feb;27(2):325-35. doi: 10.1210/me.2012-1302. Epub 2012 Nov 30. Mol Endocrinol. 2013. PMID: 23204328 Free PMC article.

9

Orexin regulates bone remodeling via a dominant positive central action and a subordinate negative peripheral action.

Wei W, Motoike T, Krzeszinski JY, Jin Z, Xie XJ, Dechow PC, Yanagisawa M, Wan Y. Wei W, et al. Among authors: wan y. Cell Metab. 2014 Jun 3;19(6):927-40. doi: 10.1016/j.cmet.2014.03.016. Epub 2014 May 1. Cell Metab. 2014. PMID: 24794976 Free PMC article.

10

Nur77 prevents excessive osteoclastogenesis by inducing ubiquitin ligase Cbl-b to mediate NFATc1 self-limitation.

Li X, Wei W, Huynh H, Zuo H, Wang X, Wan Y. Li X, et al. Among authors: wan y. Elife. 2015 Jul 14;4:e07217. doi: 10.7554/eLife.07217. Elife. 2015. PMID: 26173181 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,000 results

Search Page

Filters